D-0659-2026 Class II Ongoing

Recalled by Asclemed USA Inc. — Torrance, CA

FDA drug recall D-0659-2026 was initiated by Asclemed USA Inc. on Jun 8, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Jun 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

USA Nationwide

Code information

Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0659-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0659-2026. Report a data issue: hello@regdatalab.com.